![]() |
市场调查报告书
商品编码
1354318
药品品质管理系统市场规模 - 依解决方案类型(监管与合规管理、文件管理、审计管理)、部署模型(基于云端)、企业规模(大型企业)、全球预测,2023 - 2032Pharmaceutical Quality Management Systems Market Size - By Solution Type (Regulatory & Compliance Management, Document Management, Audit Management), Deployment Model (Cloud-based), Enterprise Size (Large Enterprise), Global Forecast, 2023 - 2032 |
药品品质管理系统市场规模预计从2023年到2032年复合年增长率约为13.1%。严格的监管标准和品质控制措施正在推动对药品品质管理系统的需求。
这些系统在确保遵守监管准则以及维护产品品质和安全方面发挥关键作用。随着製药公司努力简化营运、减少错误并提高产品质量,QMS 解决方案的采用率正在上升。例如,全球医疗保健和製药公司赛诺菲正在实施云端软体供应商 Veeva Systems 的 Veeva Vault QMS。此举背后的原因是公司要为其客户实现品质管理和客户保健 (CHC) 的现代化。
药品品质管理系统市场根据解决方案类型、部署模型、企业规模和区域进行划分。
2023 年至 2032 年,文件管理解决方案类型细分市场的复合年增长率将达到 14.1%。文件管理系统可协助製药公司有效组织、储存和管理关键文件和记录。随着监管文件的复杂性不断增加以及即时存取资讯的需求,製药公司正在采用先进的文件管理解决方案,以提供增强的协作、版本控制和合规性功能。
由于需要完全控制资料和基础设施,预计 2023 年至 2032 年本地部署模型部分的复合年增长率将达到 12.7%。本地部署提供增强的安全性、自订选项以及与现有系统无缝整合的能力。随着资料隐私和安全问题的不断升级,这些模型预计将保持其相关性,并对整体市场成长做出重大贡献。
预计2023 年至2032 年,亚太地区药品品质管理系统市场规模的复合年增长率将达到13.6%。随着製药业的快速发展、研发投资的增加以及对产品品质和安全性的日益关注,对药品品质管理系统的需求不断增长。该地区的 QMS 解决方案。中国和印度等国家的监管机构也正在收紧品质标准,进一步推动品质管理系统解决方案的采用。
Pharmaceutical Quality Management Systems Market size is expected to witness around 13.1% CAGR from 2023 to 2032. Stringent regulatory standards and quality control measures are propelling the demand for pharmaceutical quality management systems.
These systems play a pivotal role in ensuring compliance with regulatory guidelines and maintaining product quality and safety. As pharmaceutical companies strive to streamline their operations, reduce errors, and enhance product quality, the adoption of QMS solutions is on the rise. For instance, Sanofi, global healthcare and pharmaceutical company, is implementing the Veeva Vault QMS by Veeva Systems, a cloud software provider. The reason behind this move was for the company to modernize quality management and customer healthcare (CHC) for its customers.
The pharmaceutical quality management systems market is divided based on solution type, deployment model, enterprise size, and region.
The document management solution type segment will witness 14.1% CAGR from 2023 to 2032. Document management systems help pharmaceutical companies efficiently organize, store, and manage critical documents and records. With the increasing complexity of regulatory documentation and the need for real-time access to information, pharmaceutical companies are embracing advanced document management solutions that offer enhanced collaboration, version control, and compliance capabilities.
The on-premise deployment model segment is predicted to reach 12.7% CAGR from 2023 to 2032 due to the need for complete control over data and infrastructure. On-premise deployments offer enhanced security, customization options, and the ability to integrate with existing systems seamlessly. As data privacy and security concerns continue to escalate, these models are expected to maintain their relevance and contribute significantly to the overall market growth.
Asia Pacific pharmaceutical quality management systems market size is anticipated to observe 13.6% CAGR from 2023 to 2032. With a rapidly growing pharmaceutical industry, increased investments in research and development, and a rising focus on product quality and safety, there is a growing demand for QMS solutions in this region. Regulatory agencies in countries like China and India are also tightening their quality standards, further propelling the adoption of QMS solutions.